Clinical Rheumatology

, Volume 31, Issue 2, pp 259–269

Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study

  • Arvind Chopra
  • Manjit Saluja
  • Girish Tillu
  • Anuradha Venugopalan
  • Gumdal Narsimulu
  • Rohini Handa
  • Lata Bichile
  • Ashwinikumar Raut
  • Sanjeev Sarmukaddam
  • Bhushan Patwardhan
Original Article


Hydroxychloroquine sulfate (HCQS) is a popular disease-modifying antirheumatic drug (DMARD) despite modest efficacy and toxicity. Ayurveda (ancient India medicinal system) physicians treat rheumatoid arthritis (RA) with allegedly safer herbal formulations. We report a head-to-head comparison in an exploratory drug trial. The objective is to compare standardized Ayurvedic formulations and HCQS in the treatment of RA. One hundred twenty-one patients with active moderately severe RA (ACR 1988 classified) were randomized into a 24-week investigator-blind, parallel efficacy, three-arm (two Ayurvedic and HCQS) multicenter drug trial study; polyherb (Tinospora cordifolia and Zingiber officinale based) and monoherb (Semecarpus anacardium). Study measures included joint counts (pain/tenderness and swelling), pain visual analogue scale, global disease assessments, and health assessment questionnaire. Oral meloxicam (fixed-dosage schedule) was prescribed to all patients during the initial 16 weeks. Patients on prednisolone could continue a fixed stable dose (<7.5 mg daily). Rescue oral use of paracetamol was permitted and monitored. All groups matched well at baseline. An intent-to-treat analysis (ANOVA, significance P < 0.05) did not show significant differences by treatment groups. In the polyherb, monoherb, and HCQS arms, 44%, 36%, and 51%, respectively, showed ACR 20 index improvement. Several efficacy measures improved significantly in the HCQS and polyherb groups with no difference between the groups (corrected P). However, the latter was individually superior to monoherb. Only mild adverse events (gut and skin, and none withdrew) were reported with no differences between the groups. Forty-two patients dropped out. This preliminary drug trial controlled for HCQS demonstrated a standardized Ayurvedic polyherb drug to be effective and safe in controlling active RA. A better-designed study with a longer evaluation period is recommended.


Ayurveda Botanical medicinal product Clinical trial Complementary and alternative medicine Rheumatoid arthritis 


  1. 1.
    Barnes PM, Bloom B, Nahin RL (2008) Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports, no. 12. National Center for Health Statistics, HyattsvilleGoogle Scholar
  2. 2.
    Sharma PV (1994) Caraka Samhita (English translation). Chikitsa Sthana, Chapter 28. Chaukhambia Orientalia, DelhiGoogle Scholar
  3. 3.
    Srikanta Murthy KR (1993) Madhava Nidanam (roga viniscaya) of Madhavakara (English translation), chapter 22. Chaukhambia Orientalia, DelhiGoogle Scholar
  4. 4.
    Chopra A (2002) Ayurvedic medicine. Core concept, therapeutic principles, and current relevance. Med Clin N Am 86:75–89PubMedCrossRefGoogle Scholar
  5. 5.
    Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33(1–2):91–95PubMedCrossRefGoogle Scholar
  6. 6.
    Chopra A, Lavin P, Patwardhan B, Chitre D (2000) Randomized double blind trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol 27:1365–1372PubMedGoogle Scholar
  7. 7.
    Chopra A, Lavin P, Patwardhan B, Chitre D (2004) A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug on osteoarthritis of the knees. J Clinical Rheumatol 10:236–245CrossRefGoogle Scholar
  8. 8.
    Chopra A, Saluja M, Patil J, Anuradha V, Bichile L (2004) IRA-01, an Ayurvedic (Asian Indian) drug for rheumatoid arthritis (RA): evaluation for efficacy and safety, and a probable lipid modifying effect. Ann Rheum Dis 63:275Google Scholar
  9. 9.
    Chopra A, Saluja M, Tillu G, Venugopalan A, Sarmukkadam S, Raut AK et al (2011) A randomized controlled exploratory evaluation of standardized Ayurvedic formulations in symptomatic osteoarthritis knees: a government of India NMITLI project. Evid Based Complement Alternat Med 2011:724291. doi:10.1155/2011/724291 PubMedCrossRefGoogle Scholar
  10. 10.
    Patwardhan B, Vaidya ADB, Chorghade M, 6 (2004) Ayurveda and natural products drug discovery. Current Science 86:789–799Google Scholar
  11. 11.
    Mashalkar R (2008) Second World Ayurveda Congress (theme: Ayurveda for the future)—inaugural address: part I. Lecture Series eCAM 5(2):129–131Google Scholar
  12. 12.
    Mashalkar R (2008) Second World Ayurveda Congress (theme: Ayurveda for the future)—inaugural address: part II. Lecture Series eCAM 5(3):243–245Google Scholar
  13. 13.
    Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR et al (2008) American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis & Rheumatism (Arthritis Care & Research) 59:762–784CrossRefGoogle Scholar
  14. 14.
    Gogate VM (2000) Ayurvedic text on clinical pharmacology In: Ayurvedic pharmacology and therapeutic uses of medicinal plants—Dravyaguna Vidnyan, 1st English edn. Bharatiya Vidya Bhavan, Mumbai, 310Google Scholar
  15. 15.
    (2001) The Ayurvedic pharmacopoeia of India, vol. I: part I. Reprint. The Controller of Publications, Delhi. ISBN: 81-901151-3-8.Google Scholar
  16. 16.
    OECD Guidelines Number 423. Available at
  17. 17.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  18. 18.
    Bellamy N (1993) Musculoskeletal clinical metrology. Kluwer Academic, BostonCrossRefGoogle Scholar
  19. 19.
    Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B et al (1993) The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36:729–740PubMedCrossRefGoogle Scholar
  20. 20.
    Chopra A (2004) Rheumatology: made in India (Camps, COPCORD, HLA, Ayurveda, HAQ, WOMAC and drug trials). J Indian Rheum Assoc 12:43–53Google Scholar
  21. 21.
    Felson DT, Anderson JJ, Boers M et al (1995) American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38:727–735PubMedCrossRefGoogle Scholar
  22. 22.
    Chopra A, Saluja M, Tillu G (2010) Ayurveda–modern medicine interface: a critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis. J Ayurveda Integr Med 1(3):190–198PubMedCrossRefGoogle Scholar
  23. 23.
    Chopra A, Narasimulu G, Bichile L et al (2007) Comparing Ayurvedic (Indian) herbal drugs and HCQS (hydroxychloroquine sulphate) in the treatment of rheumatoid arthritis (RA): A randomized, double blind, multi-centric exploratory drug trial of 24 weeks duration. Arthritis & Rheumatism 56(9):394–395, AbstractGoogle Scholar
  24. 24.
    Thatte U, Chhabria S, Karandikar SM, Dahanukar S (1987) Immuno-therapeutic modifications by Indian medicinal plants. Indian Drugs 25:85–87Google Scholar
  25. 25.
    Thatte UM, Dahanukar SA (1989) Immunotherapeutic modification of diverse infectious states by Indian medicinal plants. Phytother Res 3:43–48CrossRefGoogle Scholar
  26. 26.
    Rege NN, Thatte UM, Dahanukar SA (1999) Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 13:275–291PubMedCrossRefGoogle Scholar
  27. 27.
    Budhiraja RD, Sudhir S (1987) Review of biological activity of withanolides. J Sci Ind Res 46:400–408Google Scholar
  28. 28.
    Ghosal S, Lal J, Shrivastava R, Bhattacharya SK, Upadhyay SN, Jaiswal AK et al (1989) Immunomodulatory and CNS effects of sitoinosides IX and X, two new glycowithanolides from W. somnifera. Phytother Res 3:201CrossRefGoogle Scholar
  29. 29.
    Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B (1996) Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol 50:69–76PubMedCrossRefGoogle Scholar
  30. 30.
    Chopra A, Patil J, Doiphode V, Patwardhan B (2001) Exploring ancient Ayurveda for rheumatology: traditional therapy, modern relevance and challenges. APLAR J Rheumatol 4:190–199Google Scholar
  31. 31.
    Sumantran V, Kulkarni A, Chandwaskar R, Harsulkar A, Patwardhan B, Chopra A, Wagh U (2007) Chondroprotective potential of fruit extracts of Phyllanthus emblica in osteoarthritis. Evid Based Complement Alternat Med 5:329–335CrossRefGoogle Scholar
  32. 32.
    Sumantran V, Kulkarni A, Boddul S, Chinchwade T, Koppikar S, Harsulkar A, Patwardhan B, Chopra A, Wagh U (2007) Chondoprotective potential of root extracts of Withania somnifera in osteoarthritis. J Biosci 32(2):299–307PubMedCrossRefGoogle Scholar
  33. 33.
    Chopra A (2000) Ayurvedic medicine and arthritis. Rheum Dis Clin North Am 26:133–144PubMedCrossRefGoogle Scholar
  34. 34.
    Myasoedova E, Davis JM, Crowson DS, Gabriel SE (2012) Epidemiology of rheumatoid arthritis and mortality. Curr Rheumatol Rep 12:379–385CrossRefGoogle Scholar
  35. 35.
    Felson DT, Anderson JJ, Meenan RF (1990) The comparative efficacy and toxicity of second line drugs in rheumatoid arthritis: results of two meta-analyses. Arthritis Rheum 33(10):1449–1461PubMedCrossRefGoogle Scholar
  36. 36.
    Little CV, Parsons T (2001) Herbal therapy for treating rheumatoid arthritis. Cochrane Database of Syst Rev (1):CD002948. doi:10.1002/14651858.CD002948
  37. 37.
    Soeken KL, Miller SA, Ernst E (2003) Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology 42:652–659PubMedCrossRefGoogle Scholar
  38. 38.
    Salahuddin A, Jeremy A, Charles JM, Haqqi TM (2005) Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med 2(3):301–308. doi:10.1093/ecam/neh117 CrossRefGoogle Scholar
  39. 39.
    Chopra A, Saluja M, Tillu G (2010) Ayurveda modern medicine interface: a critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis. J Ayurveda Integrative Med (J-AIM) V1(3):190–198CrossRefGoogle Scholar
  40. 40.
    Bansal D, Hota D, Chakrabarti A (2010) Research methodological issues in evaluating herbal interventions. Open Access Journal of Clinical Trials 2:15–21Google Scholar
  41. 41.
    Tonelli MR, Callahan TC (2001) Why alternative medicine cannot be evidence based? Acad Med 76(12):1213–1220PubMedCrossRefGoogle Scholar
  42. 42.
    Fonnebo V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H et al (2007) Researching complementary and alternative treatments—the gatekeepers are not at home. BMC Med Res Methodol 7:7. doi:10.1186/1471-2288-7-7 PubMedCrossRefGoogle Scholar
  43. 43.
    Narahari SR, Ryan TJ, Aggithaya MG, Bose KS, Prasanna KS (2008) Evidence based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model. The J of Alternative and Complementary Medicine 14(6):769–776CrossRefGoogle Scholar
  44. 44.
    MacPherson H (2004) Pragmatic clinical trials. Complementary Therapies in Medicine 12:136–140PubMedCrossRefGoogle Scholar
  45. 45.
    Elder C, Aickin M, Bauer V et al (2006) Randomized trial of a whole-system Ayurvedic protocol for type 2 diabetes. Alternative Therapies 12(5):24–30Google Scholar
  46. 46.
    Sarmukaddam S, Chopra A, Tillu G (2010) Efficacy and safety of Ayurvedic medicines: recommending equivalence trial design and proposing safety index. International J Ayurveda Res (IJAR) V1(3):175–180CrossRefGoogle Scholar
  47. 47.
    Mashalkar R (2008) Second World Ayurveda Congress (theme: Ayurveda for the future)—inaugural address: part III. Lecture Series eCAM 5(4):367–369Google Scholar
  48. 48.
    Chopra A, Saluja M, Tillu G (2011) Diet, Ayurveda and interface with biomedicine (letter to the editor). J Ayurveda Integr Med 1:243–244. doi:10.4103/0975-9476.74423 CrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2011

Authors and Affiliations

  • Arvind Chopra
    • 1
  • Manjit Saluja
    • 1
  • Girish Tillu
    • 2
  • Anuradha Venugopalan
    • 1
  • Gumdal Narsimulu
    • 3
  • Rohini Handa
    • 4
  • Lata Bichile
    • 5
  • Ashwinikumar Raut
    • 5
  • Sanjeev Sarmukaddam
    • 1
  • Bhushan Patwardhan
    • 2
  1. 1.Centre for Rheumatic Diseases (CRD)PuneIndia
  2. 2.Interdisciplinary School of Health Sciences (SHS)University of PunePuneIndia
  3. 3.Rheumatology DepartmentNizam Institute of Medical Sciences (NIMS)PanjaguttaIndia
  4. 4.Rheumatology DepartmentAll India Institute of Medical Sciences (AIIMS)New DelhiIndia
  5. 5.Rheumatology DepartmentKEM Hospital and GS Medical College and SPARCMumbaiIndia

Personalised recommendations